Prudential plc’s Dr. Reddy's Laboratories RDY Stock Holding History

Prudential plc’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-172,283	Closed	-$2.59M	–	768
2025 Q2	$2.59M	Hold	172,283	–	–	0.02%	374
2025 Q1	$2.27M	Hold	172,283	–	–	0.01%	368
2024 Q4	$2.71M	Buy	+172,283	New	+$2.59M	0.01%	335
2019 Q4	–	Sell	-27,000	Closed	-$205K	–	718
2019 Q3	$205K	Hold	27,000	–	–	﹤0.01%	756
2019 Q2	$202K	Hold	27,000	–	–	﹤0.01%	731
2019 Q1	$219K	Sell	27,000 -26,000	-49%	-$198K	﹤0.01%	634
2018 Q4	$400K	Hold	53,000	–	–	﹤0.01%	554
2018 Q3	$367K	Sell	53,000 -107,000	-67%	-$715K	﹤0.01%	593
2018 Q2	$1.03M	Buy	160,000 +107,000	+202%	+$675K	﹤0.01%	496
2018 Q1	$347K	Buy	+53,000	New	+$371K	﹤0.01%	613

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential plc's RDY Position: Q3 2025 in Review

Prudential plc sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 172,283 shares — an estimated $2.59M sold.

Prudential plc first reported a position in RDY in Q1 2018 and held it in 10 quarters. The position peaked at $2.71M in Q4 2024. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

Prudential plc reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
Prudential plc sold 172,283 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $2.59M.
Prudential plc first reported a position in Dr. Reddy's Laboratories in Q1 2018 and held it in 10 quarters.
Prudential plc's Dr. Reddy's Laboratories position peaked at $2.71M in Q4 2024.
228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Prudential plc's 13F filing for Q3 2025, filed 14 Nov 2025.